Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;36(8):5971-7.
doi: 10.1007/s13277-015-3273-x. Epub 2015 Mar 6.

Combined effects of anticancer drugs and new synthetic α-methylene-δ-lactones on MCF-7 cells

Affiliations
Free article

Combined effects of anticancer drugs and new synthetic α-methylene-δ-lactones on MCF-7 cells

Katarzyna Gach et al. Tumour Biol. 2015 Aug.
Free article

Abstract

The search for novel drug candidates is a priority goal for cancer therapy. Natural products isolated from plants are often used as valuable leads for the synthesis of analogs with simpler structure. Two synthetic α-methylene-δ-lactones with chroman-2-one skeleton, designated DL-3 and DL-5, exhibiting strong cytotoxic activity against several cancer cell lines, have been tested alone and in combination with well-known anticancer drugs, 5-fluorouracil, oxaliplatin, and taxol, in breast cancer MCF-7 cells. Parthenolide, a plant-derived α-methylene-γ-lactone, was used as a positive control. The effects on cell proliferation, DNA damage, and apoptosis induction were evaluated. Neither of the tested compounds significantly enhanced the effects produced by taxol, but a strong synergistic effect was observed with 5-fluorouracil and oxaliplatin. Only small differences between the actions of both α-methylene-δ-lactones were found. The synergistic effects produced by these compounds in MCF-7 cells were stronger as compared with parthenolide. Our findings show that simple and easy-to-obtain synthetic compounds with α-methylene-δ-lactone motif can potentiate the efficiency of anticancer drugs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 2002 Oct 11;277(41):38954-64 - PubMed
    1. Cancer Lett. 2013 Jul 28;335(2):479-86 - PubMed
    1. Science. 1977 Apr 29;196(4289):533-6 - PubMed
    1. Cancer Res. 2007 Apr 1;67(7):3371-8 - PubMed
    1. J Am Chem Soc. 1968 Jun 19;90(13):3596-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources